The Warnings Page: Ephedra Recall in Canada; FDA Investigates Kava; Bristol-Myers, Novartis Issue Warnings
January 31, 2002
Canada Recalls Ephedra-Containing Products
icTendiche Canadian regulatory health agency has requested a recall of certain products containing ephedra, warning consumers that they pose a serious risk to their health.
photo-2Health Canada, the Canadian equivalent of the FDA, said in a statement issued Jan. 9 that following a risk assessment of ephedra-containing products, it has concluded that products containing the supplement should be recalled from all levels of the market, including retail.
"Adverse events including stroke, heart attacks, heart rate irregularities, seizures, psychoses and deaths have been reported in association with the use of some …
UPCOMING CONFERENCES

HarrisMartin's Mass Tort Settlements Conference - Sponsored by Milestone
June 25, 2025 - Buffalo, NY
The Westin Buffalo